HIGHLIGHTS
- who: Christine Espinola-Klein from the University of Aberdeen, United Kingdom have published the article: Antithrombotic therapy in peripheral arterial disease, in the Journal: (JOURNAL)
- what: The study was early stopped because of a significant superiority of combination therapy compared to ASA 100 monotherapy.
- future: Future direction includes the development of risk assessment models to stratify ischemic and bleeding risk in patients with PAD and to evaluate new antithrombotic regimes which may improve efficacy and safety for patients with PAD.
SUMMARY
To the consistent management of cardiovascular risk factors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.